Abcam appoints Alan Hirzel as Chief Marketing Officer

  • New role will support future growth strategies at Abcam

Cambridge UK, June, 27, 2013: Abcam Plc., a global leader in the supply of protein research tools, announced today that it has appointed Alan Hirzel as Chief Marketing Officer. This is a new position, based at Abcam’s Headquarters in Cambridge, UK, which will strengthen Abcam’s management team and support the company in delivering its growth strategies.

Alan will take responsibility for Abcam’s branding, product portfolio and online consumer offering. He joins Abcam on 5th August 2013.

Alan has over 20 years of global business and leadership experience. Prior to joining Abcam, he spent 14 years with leading management consultant Bain & Company, most recently serving as head of the UK Healthcare Practice and head of its London office operations. Whilst at Bain, Alan advised a wide range of global brand executives on consumer and marketing strategies to help achieve growth targets.

Alan serves as a Trustee at The Social Business Trust, and has recently been appointed to the board of UK National Citizen Service. Alan has a B.S. in Plant Molecular Biology and M.S. from Cornell University, and an MBA from the Johnson Graduate School of Business at Cornell.

Jonathan Milner, CEO of Abcam, commented: “We are pleased to welcome Alan to Abcam at an exciting time for the company, which sees many new growth opportunities. Alan’s life science background, and his business and leadership experience, will be of immense value to Abcam as it continues its quest to become the world-leading life science tools company.”

Contacts:

Abcam
Francesca Axe
T: +44 (0) 1223 696000

Media enquiries
Katie Odgaard
Zyme Communications
E: katie.odgaard@zymecommunications.com
T: +44 (0) 7787 502 947

Abcam Welcomes Students from Cambridge Regional College

  • BTEC Science Diploma students take part in a series of talks and practical demonstrations at Abcam’s lab in Cambridge, UK.

Abcam Plc., a producer and distributor of high quality protein research tools, welcomed a group of students studying for the BTEC Science Diploma at Cambridge Regional College to take part in a series of activities at its Cambridge headquarters on Tuesday 26th March. The visit was designed to give the students some experience of what it is like to work in a busy, successful working laboratory.

The students enjoyed a series of educational, scientific talks from Sarah Bolt, Head of Characterisation Services, and Wyn Forrest-Owen, Head of Production Sciences, during which they learned about the production of Abcam’s products, and how scientists use the reagents in their research. Abcam’s Resourcing Advisor, Claire Warburton, also gave the students some practical tips on writing a CV and applying for jobs in the science industry. The visit finished with a tour of the laboratory where the production and testing of some of Abcam’s products takes place.

Abcam Welcomes Students from Cambridge Regional College

Claire Sellick, Biology Lecturer at Cambridge Regional College, said: “The visit has been really inspirational for our students and has helped them better understand the day-to-day running of a lab at a successful biotech company. We’re grateful to Abcam for taking the time to support and encourage our students with their studies.”

Wyn Forrest-Owen, Head of Production Sciences said: “We hope that we’ve been able to excite the next generation of scientists about their future careers in the industry. Today will have given the students a little insight into the practical skills and knowledge required to be a successful scientist.”

 

Contact information

Francesca Axe
Abcam
+44 (0) 1223 696000

Lorna Cuddon
Zyme Communications
+44 (0)7787 502 947
katie.odgaard@zymecommunications.com

Abcam donates an additional £45,000 to local charities

  • Cambridge, UK based Red Balloon, Winter Comfort, and Cambridge Community Foundation, to benefit

Cambridge, UK, March 18, 2013: Abcam Plc, producer and distributor of high quality protein research tools, today announced its support for local good causes by donating an additional £45,000 to three local charities (£15,000 each). The three charities are: Red Balloon, a charity to support the recovery of bullied children; Winter Comfort, a social initiative to help the homeless; and Cambridge Community Foundation, a local charity working to connect a range of donors to local good causes.

“Supporting our community is really important to Abcam. We’ve been incredibly fortunate over the years and are now really pleased to be able to now give something back, providing support at what is a critical point for some of these charities. We look forward to helping other good causes in the future,” commented Jonathan Milner, CEO, Abcam.

Abcam donates to Red Balloon

Jacob Gray from Abcam’s Charity Committee presents a £15,000 cheque to Carrie Herbert, Chief Executive of Red Balloon.

Abcam also regularly donates to a range of national and international causes through its Charity Committee. The Committee, which consists of Abcam employees, has been administrating funding to charities since 2004.

Rachel Newell, Social Enterprise and Business Development Manager, Wintercomfort, said: “We would like to thank Abcam for their donation. We’re looking at developing new initiatives that will give those that that are homeless or vulnerably housed the skills to help them get back into employment and this money will help support any current and future projects.”

Jane Darlington, CEO of Cambridge Community Foundation, said: “We are delighted to welcome Abcam as the latest member of our Community Foundation 100 initiative. Through this initiative we are bringing 100 local companies and people together to collectively support local voluntary and community groups that are working hard to improve the quality of life across the communities of Cambridgeshire.”

Dr. Carrie Herbert, Founder and Chief Executive of Red Balloon, said: “It is heart-warming when a successful local business supports a local charity which is now a national organization. With Abcam’s help we shall be able to grow and deliver our recovery program to severely bullied and traumatized children who are unable to go to school.” 

Contact information

Francesca Axe
Abcam
+44 (0) 1223 696000

Lorna Cuddon
Zyme Communications
+44 (0) 7811 996942

Abcam helps contribute to growth of hi-tech sector in Cambridge, UK

A recent case study by the Greater Cambridge and Greater Peterborough Enterprise Partnership showcases Abcam’s efforts in contributing to the growth of the hi-tech sector in the local region.

The Greater Cambridge Greater Peterborough Enterprise Partnership is focused on helping to drive forward sustainable economic growth in the area – with local business, education providers, the third sector and the public sector working together to achieve this.

“Abcam represents what Cambridge can offer in terms of technology and innovation.”

“We’re well networked with other forward thinking local organisations who are striving for similar goals within the hi-tech sector.”

– Chief Operating Officer, Jim Warwick

We have reached 100,000 products

We are proud that we can now give more choice to customers than ever before as we reach our important milestone of 100,000 products on our catalog. Our expanding product range now includes a range of non-primary antibody products including biochemicals, secondaries, proteins, peptides, lysates, assays and other kits.

Our commitment to customers still remains the same. We’ll continue to provide the best catalog of products accompanied by expert technical support, the most up-to-date and honest data and fast global delivery.

We would like to thank our customers for their continued support and we look forward to helping them on their quest for discovery.

HRH The Duke of York visits Abcam to see the Cambridge Phenomenon in action

Duke of York visits AbcamOctober 09, 2012:  Abcam gave a special welcome to His Royal Highness The Duke of York at their global headquarters in Cambridge.

The Duke’s tour of Abcam was part of a larger visit showcasing Cambridge as a high-tech cluster where the combination of the University, flexible funding sources and existing know-how can foster the growth of world-class companies.

During his visit, His Royal Highness met with Abcam’s founder and CEO, Dr. Jonathan Milner and Jim Warwick, Abcam’s Chief Operating Officer who gave an overview of Abcam’s origins from the University and recent global developments.

His Royal Highness received a tour of Abcam’s operations and production facilities. This included an overview of storage facilities for Abcam’s new product types and the processes that ensure fast global delivery of products to researchers worldwide.

The tour finished with a visit to the Product Development Manufacturing facility where Abcam undertakes extensive testing of their products to ensure they are the highest quality for customers.

“The Duke’s visit comes at an exciting time for Abcam as we take huge strides towards becoming the world’s leading supplier of life science research tools. His Royal Highness was shown how improved operations and product development manufacturing processes enable Abcam to efficiently serve their global base of customers in more than 130 countries.”

“We are delighted that His Royal Highness was able to take the time to visit Abcam and recognise the developments we have made in helping researchers worldwide with their life science discoveries.”

– Jim Warwick, Chief Operating Officer, Abcam plc

For further information contact:
Francesca Axe
Abcam: +44 (0) 1223 696000

Rabbit monoclonal antibodies, available from Abcam following acquisition of Epitomics

September 4, 2012: Abcam is pleased to announce that following the completion of the acquisition of Epitomics, customers in Europe are now able to purchase Epitomics’ line of high quality RabMAbs® (Rabbit Monoclonal Antibodies) directly from our website.

RabMAbs® provide the combined benefits of superior antigen recognition of the rabbit immune system with the specificity and consistency of a monoclonal antibody, bringing you the highest quality antibody possible.

This move will enhance the service and support for our European customers who will now be able to receive Epitomics research products in a much shorter time frame than previously possible. Most European countries will now receive Epitomics research products via Abcam’s next day delivery service. Abcam’s multi-lingual technical support teams will also be available to answer questions regarding Epitomics products.

Epitomics products can be found directly on Abcam’s website or on Epitomics’ website. Customers in Europe wishing to place orders for Epitomics research products will be able to purchase directly with Abcam.

For a complete list of countries where Epitomics research products can be ordered from and for further details, please visit Epitomics or Abcam. Please note that Epitomics IVD products will continue to be sold through Epitomics existing distribution network.

The acquisition of Epitomics, Inc. now known as Epitomics – an Abcam Company, extends Abcam’s product portfolio, including RabMAbs® research antibodies, EP Clone antibodies for Immunohistochemistry (In Vitro Diagnostics Range) and Custom Antibody Development Services, in line with Abcam’s vision of becoming the world’s leading supplier of life science research tools.

About Epitomics

Epitomics, Inc. is a biotechnology company dedicated to developing breakthrough rabbit monoclonal antibody technology for research and diagnostic applications. The Company’s core technology is its unique and proprietary RabMAbs® (Rabbit Monoclonal Antibody) technology which produces antibodies with superior binding affinity and bioactivity in a wide variety of biological assays.

Epitomics, Inc. was founded in 2001, headquartered in Burlingame, California, and operates a wholly owned subsidiary in Hangzhou, the People’s Republic of China.

Epitomics, Inc. is now known as Epitomics – an Abcam Company.

New range of Biochemicals now available from Abcam

Abcam Biochemcials

January 9, 2012: Abcam has today launched a new range of exceptional quality and high performance biochemicals.  The products include high purity agonists, antagonists, channel blockers, enzyme inhibitors and signaling tools for life science researchers.

The acquisition extends Abcam’s product portfolio into bioactive small molecules and is in line with the Company’s vision of becoming the world’s leading supplier of protein research tools.

Commenting on the launch, Steve Roome (Abcam Biochemicals General Manager) said:

“The launch extends Abcam’s product portfolio into small molecules and offers customers a great choice of high purity pharmacological and signaling life science reagents.  Customers will benefit from the same fast delivery, product guarantee and multilingual scientific support as they do for all Abcam products.

We intend to rapidly expand the range and are confident Abcam Biochemicals will fast become the researchers choice for high quality and high performance biochemical tools.”

Ordering
Researchers who previously ordered Ascent Scientific products can now order Abcam Biochemicals via the Abcam website and through authorized distributors.  Products carry the same ASC product code as before for ease of search.

For further information contact:

Abcam: +44 01223 696000

Jonathan Milner wins Entrepreneur of the Year award

  • Abcam’s CEO wins the prestigious AIM award for Entrepreneur of the Year, 2010

Jonathan says; “It’s an honour to be voted Entrepreneur of the Year and I accept the award on behalf of everyone at Abcam. The success of Abcam is a result of all employees striving for excellence in every aspect of our business, which I am pleased to acknowledge in receiving this award”.

AIM awards

Sponsored by PwC, the AIM awards dinner is now in its 15th year attracting 1,300 guests. The AIM club gathers to celebrate outstanding achievement on the world’s most successful growth market.

View the rest of the AIM winners.

300th employee hired